BenevolentAl Therapeutics Pipeline and Triage
My
We combine deep expertise in Drug Discovery with innovative
techniques in structure-based design, virtual screening and machine
learning
Highly experienced Drug Discovery team with a proven track
record of taking nascent programme ideas and delivering drugs to
the clinic.
✔ Chemoinformatic and Al tools impacting all stages of a drug
programme from target selection through to candidate selection,
by:
Identifying differentiated opportunities through novel binding
sites and prioritising previously undrugged targets for exploitation.
✓ Maximising the use of available data to derive new knowledge,
at scale, for objective molecular design.
✔ Empowering chemists to design better drugs in fewer cycles -
Candidate drugs delivered in as little as 2 years from programme
inception, compared to a 3-5 year industry standard².
HO
OH
1 Based on BEN-8744 timelines - see Portfolio Overview deck November 2021 for more information?
https://misciwriters.com/2019/11/15/from-the-lab-to-your-medicine-cabinet-a-timeline-of-drug-development/
ΑΙ
Benevolent 29View entire presentation